High-end medical manufacturing industry has been listed in the top 10 areas of Made-in-China 2025. We look forward to the emergence, shaping and perfection of "the most important tool of the country" as soon as possible. Below, excerpts are Caitong Securities Research Newspaper, "Medical Devices Areas also Need the Most Important Devices of the Country", for readers'reference.

 

 

 

Caitong Securities Pharmaceutical Group's deduction of the outcome of the Sino-US trade war has analyzed two situations. One is reconciliation. Considering the requirements of the United States, China should strengthen the protection of intellectual property rights and reduce import barriers, including tariffs and other domestic administrative barriers. In the long run, it is also conducive to the upgrading of innovative drugs and devices.

 

 

 

The other is to upgrade the trade war to a technology war. The United States has put pressure on China with core technology, such as the recent ZTE incident. It will make great efforts in core technology and independent innovation. Therefore, it will also vigorously enhance the technological upgrading of domestic devices and vigorously promote import substitution.

 

 

 

At the National Conference on network security and information technology held recently, national leaders attended the conference peacefully and delivered important speeches. The Seventh Standing Committee attended with the highest specifications.

 

 

 

The meeting emphasized that "core technology is the most important tool of a country". Specific methods include: 1. Pay attention to the construction of industrial system; 2. Do a good job of systematic technology layout, select the best among the best and break through the key points. 3. Improve the institutional environment of finance, taxation, international trade, talent and intellectual property protection, optimize the market environment, and better release the innovative vitality of all kinds of innovators.

 

 

 

The policy will obviously give firm support to domestic innovation. For domestic medical device enterprises, especially Lepu Medical, many fields are accelerating the development of high-end innovative medical devices and developing imported alternatives, such as degradable stents, dual-chamber pacemakers, degradable occluders, heart valves and so on.

 

 

 

Opcom's Corneal Plastic Mirror also needs to be imported in terms of materials, and also competes with international technology in terms of processing and manufacturing.

 

 

 

For large-scale medical devices, domestic enterprises will also actively support, such as Wandong Medical, Myry, Syndicate, open medical treatment, and so on. Relevant enterprises will benefit from a policy climate that encourages innovation.

 

 

 

Cypress Blue Instruments participated in the Blue Paper Conference issued by China Medical Material Association in mid-April this year. Its Blue Paper on the Development of China Medical Device Industry in 2017 shows that in recent years, China's high-end medical device industry has made rapid development with the support of the state and the efforts of enterprises, especially the influence of individual products, such as ultrasound, guardianship and other equipment in the international market has gradually become apparent. Now, image diagnostic equipment is gradually replaced by imported ones.

 

 

 

However, because the global market has been monopolized by multinational companies for a long time, the technical level and comprehensive performance of China's high-end products still lag far behind that of developed countries. The clinical use time is relatively short, and the recognition of international and domestic mainstream markets is low.